“I was first introduced to Curcumall® about five years ago by Professor Reuven Or, Head of the Bone Marrow Transplant Department of the Hadassah Medical Center in Jerusalem. During the last three years I have conducted specific research with Curcumall® and Oral Mucositis in oncologic children who were treated with chemotherapy. The results of our research suggest that Curcumall® is efficient in the prevention of OM and is recommended for use by cancer patients who undergo chemotherapy in order to avoid the development of mucositis.”